Success Metrics

Clinical Success Rate
84.3%

Based on 576 completed trials

Completion Rate
84%(576/683)
Active Trials
263(22%)
Results Posted
41%(236 trials)
Terminated
107(9%)

Phase Distribution

Ph phase_3
121
10%
Ph phase_4
86
7%
Ph phase_2
174
15%
Ph not_applicable
658
55%
Ph early_phase_1
7
1%
Ph phase_1
42
4%

Phase Distribution

49

Early Stage

174

Mid Stage

207

Late Stage

Phase Distribution1088 total trials
Early Phase 1First-in-human
7(0.6%)
Phase 1Safety & dosage
42(3.9%)
Phase 2Efficacy & side effects
174(16.0%)
Phase 3Large-scale testing
121(11.1%)
Phase 4Post-market surveillance
86(7.9%)
N/ANon-phased studies
658(60.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

76.9%

576 of 749 finished

Non-Completion Rate

23.1%

173 ended early

Currently Active

263

trials recruiting

Total Trials

1,193

all time

Status Distribution
Active(325)
Completed(576)
Terminated(173)
Other(119)

Detailed Status

Completed576
Recruiting203
unknown118
Terminated107
Withdrawn66
Active, not recruiting60

Development Timeline

Analytics

Development Status

Total Trials
1193
Active
263
Success Rate
84.3%
Most Advanced
Phase 4

Trials by Phase

Early Phase 17 (0.6%)
Phase 142 (3.9%)
Phase 2174 (16.0%)
Phase 3121 (11.1%)
Phase 486 (7.9%)
N/A658 (60.5%)

Trials by Status

completed57648%
terminated1079%
enrolling_by_invitation91%
withdrawn666%
recruiting20317%
unknown11810%
not_yet_recruiting534%
suspended10%
active_not_recruiting605%

Recent Activity

Clinical Trials (1,193)

Showing 20 of 1,193 trialsScroll for more
NCT04701437Not Applicable

Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants

Active Not Recruiting
NCT06641466Phase 3

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Recruiting
NCT07005102Phase 2

A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Recruiting
NCT07081074Not Applicable

ROS-scavenging Amino Acid-derived Lipids for the Prevention and Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer

Recruiting
NCT06892158Not Applicable

Massage Impact on Sleep in Pediatric Oncology

Recruiting
NCT06388590Not Applicable

Acupuncture for Chronic Pelvic Pain

Recruiting
NCT05630482Not Applicable

Randomized Trial of Healthy Family Foundations

Recruiting
NCT06453187Not Applicable

A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers

Enrolling By Invitation
NCT06847438Not Applicable

Tailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failure

Recruiting
NCT07260344Not Applicable

Evaluation of Two Non-Invasive Methods, High-Resolution Microendoscopy and Liquid-Based Cytology, for Detection of Oral Precancer

Recruiting
NCT07529392Phase 4

Percutaneous Auricular Vagus Nerve Stimulation With Conventional Rehabilitation Training in Chronic Back Pain Patients

Recruiting
NCT07526935Not Applicable

Combined Role of Gastric Peroral Endoscopic Myotomy and Gastric Electrical Stimulator

Active Not Recruiting
NCT04307277Phase 3

Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma

Recruiting
NCT06562296Phase 4

Study Evaluating Several CAMPs in Nonhealing Diabetic Foot and Venous Leg Ulcers

Completed
NCT05957276

Global Patient Registry of Inherited Retinal Diseases

Active Not Recruiting
NCT07451197Not Applicable

Family-Focused Study to Support Medication for Opioid Use Disorder

Not Yet Recruiting
NCT05768763Not Applicable

SEARCH SAPPHIRE Phase B

Completed
NCT04896606Phase 1

SARS-CoV-2 CTLS for Mild to Moderate COVID-19 Disease

Recruiting
NCT07194070

A Study on Hemolytic Disease of the Fetus and Newborn (HDFN) Through Global Registry

Recruiting
NCT06930768Not Applicable

Evaluating the Efficacy of NeoThelium FT in the Treatment of Venous Leg Ulcers

Not Yet Recruiting

Drug Details

Intervention Type
DRUG
Total Trials
1,193